TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fracTion
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 8505 participants.
Also called NCT03596385
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 8,505 participants
- Registry
-
NCT03596385
-
- Other papers using this trial's data
- Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction
- Beta-blockers after invasively managed STEMI vs NSTEMI without reduced ejection fraction: a prespecified analysis from the REBOOT trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Italy, Spain
- Registry status
- Completed
Technical summary
Registry record NCT03596385. Randomized; no masking; primary purpose treatment. Start 2018-10-31 (actual); primary completion 2025-01-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fracTion"
- Condition
- Myocardial Infarction
- Intervention (Drug)
- Beta blocker
- Lead sponsor
- Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
Record details
- Record id
cardio:ct-nct03596385- Content hash
668323cae480dadd948102297570da4f47ba1daff0e1f80fa046d73d858888fc